Change in HbA1c concentration as decision parameter for frequency of HbA1c measurement

被引:6
作者
Munk, Jens K. [1 ]
Lind, Bent S. [1 ]
Jorgensen, Henrik L. [1 ,2 ]
机构
[1] Hvidovre Univ Hosp, Dept Clin Biochem, Kettegard Alle 30, DK-2650 Hvidovre, Denmark
[2] Univ Copenhagen, Dept Clin Med, Copenhagen N, Denmark
关键词
Glycated Hemoglobin A; clinical laboratory information systems; clinical chemistry tests; economics; medical; GLYCATED HEMOGLOBIN; LABORATORY TESTS; A1C ASSAY;
D O I
10.1080/00365513.2019.1622032
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hemoglobin A(1c) (HbA(1c)) is a long-term measure for glucose concentration in plasma. Since its introduction as a diabetes monitoring tool, and its more recent application as a diagnostic tool, the number of measurements of HbA(1c) have risen dramatically. However, HbA(1c) change is slow, so repeating measurements should not be done too often. We use a large, unfiltered dataset from 52,017 patients to determine the possible rate of change in HbA(1c) concentration. In our laboratory, the critical difference between HbA(1c) measurements is 8.5%. Our data show that a 1-unit HbA(1c) rise takes 4 weeks to occur, hence, at a HbA(1c) concentration around 50 mmol/mol Hgb, a critically increased HbA(1c) concentration cannot be determined until after 16 weeks. Conversely a critically lower HbA1c can manifest itself after 2 weeks, but after 7 weeks the dropping tendency stops. The amount of measurements that can be cancelled because they were taken sooner than 16 weeks is 23 percent.
引用
收藏
页码:320 / 324
页数:5
相关论文
共 24 条
[1]  
Ajzner Eva, 2016, EJIFCC, V27, P166
[2]  
Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI [10.2337/dc10-s062, 10.2337/dc09-S062]
[3]  
[Anonymous], 2016, Diabetes Care, V39, pS13, DOI DOI 10.2337/DC16-ER09
[4]  
[Anonymous], 2011, USE GLYCATED HAEMOGL
[5]   Response to comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e54, 2011) [J].
Wysham, C. H. ;
Kirkman, M. S. .
DIABETES CARE, 2011, 34 (08) :1887-1887
[6]   The role of laboratory in ensuring appropriate test requests [J].
Ferraro, Simona ;
Panteghini, Mauro .
CLINICAL BIOCHEMISTRY, 2017, 50 (10-11) :555-561
[7]   Managing demand for laboratory tests: a laboratory toolkit [J].
Fryer, Anthony A. ;
Smellie, W. Stuart A. .
JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (01) :62-72
[8]   Approved IFCC reference method for the measurement of HbA1c in human blood [J].
Jeppsson, JO ;
Kobold, U ;
Barr, J ;
Finke, A ;
Hoelzel, W ;
Hoshino, T ;
Miedema, K ;
Mosca, A ;
Mauri, P ;
Paroni, R ;
Thienpont, L ;
Umemoto, M ;
Weykamp, C .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (01) :78-89
[9]   Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center [J].
Krasowski, Matthew D. ;
Chudzik, Deborah ;
Dolezal, Anna ;
Steussy, Bryan ;
Gailey, Michael P. ;
Koch, Benjamin ;
Kilborn, Sara B. ;
Darbro, Benjamin W. ;
Rysgaard, Carolyn D. ;
Klesney-Tait, Julia A. .
BMC MEDICAL INFORMATICS AND DECISION MAKING, 2015, 15
[10]   Changing the electronic request form proves to be an effective tool for optimizing laboratory test utilization in the emergency department [J].
Lapic, Ivana ;
Juros, Gordana Fressl ;
Rako, Ivana ;
Rogic, Dunja .
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2017, 102 :29-34